IRIS Accounts Production v24.3.2.46 04082214 Board of Directors 1.10.23 30.9.24 30.9.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh040822142023-09-30040822142024-09-30040822142023-10-012024-09-30040822142022-09-30040822142022-10-012023-09-30040822142023-09-3004082214ns15:EnglandWales2023-10-012024-09-3004082214ns14:PoundSterling2023-10-012024-09-3004082214ns10:Director12023-10-012024-09-3004082214ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3004082214ns10:SmallEntities2023-10-012024-09-3004082214ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3004082214ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3004082214ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3004082214ns10:FullAccounts2023-10-012024-09-3004082214ns10:OrdinaryShareClass12023-10-012024-09-3004082214ns5:CurrentFinancialInstruments2024-09-3004082214ns5:CurrentFinancialInstruments2023-09-3004082214ns5:ShareCapital2024-09-3004082214ns5:ShareCapital2023-09-3004082214ns5:RetainedEarningsAccumulatedLosses2024-09-3004082214ns5:RetainedEarningsAccumulatedLosses2023-09-3004082214ns10:RegisteredOffice2023-10-012024-09-3004082214ns5:PlantMachinery2023-10-012024-09-3004082214ns5:PlantMachinery2023-09-3004082214ns5:PlantMachinery2024-09-3004082214ns5:PlantMachinery2023-09-3004082214ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3004082214ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3004082214ns5:DeferredTaxation2023-09-3004082214ns5:DeferredTaxation2023-10-012024-09-3004082214ns5:DeferredTaxation2024-09-3004082214ns10:OrdinaryShareClass12024-09-30
REGISTERED NUMBER: 04082214 (England and Wales)
























UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

MEDICAL SOLUTIONS DELIVERED LTD

MEDICAL SOLUTIONS DELIVERED LTD (REGISTERED NUMBER: 04082214)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024










Page

Statement of Financial Position 1

Notes to the Financial Statements 2


MEDICAL SOLUTIONS DELIVERED LTD (REGISTERED NUMBER: 04082214)

STATEMENT OF FINANCIAL POSITION
30 SEPTEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 727 970

CURRENT ASSETS
Debtors 5 5,234 5,991
Cash at bank 11,602 6,346
16,836 12,337
CREDITORS
Amounts falling due within one year 6 2,229 527
NET CURRENT ASSETS 14,607 11,810
TOTAL ASSETS LESS CURRENT LIABILITIES 15,334 12,780

PROVISIONS FOR LIABILITIES 7 182 184
NET ASSETS 15,152 12,596

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 15,052 12,496
SHAREHOLDERS' FUNDS 15,152 12,596

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 March 2025 and were signed on its behalf by:





C Loveday - Director


MEDICAL SOLUTIONS DELIVERED LTD (REGISTERED NUMBER: 04082214)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. STATUTORY INFORMATION

Medical Solutions Delivered Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 04082214

Registered office: Autumn House
Bryants Bottom
Great Missenden
Buckinghamshire
HP16 0JS

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

No significant judgements (apart from those involving estimations) have been made by management in the process of applying the entity's accounting policies and preparing these financial statements.

Accounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome. There have been no key assumptions or there sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

At each balance sheet date assets not carried at fair value are assessed to determine whether there is an indication that the asset may be impaired. If there is such an indication the recoverable amount of the asset is compared to the carrying amount of the asset.

MEDICAL SOLUTIONS DELIVERED LTD (REGISTERED NUMBER: 04082214)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


2. ACCOUNTING POLICIES - continued

Financial instruments
The company holds basic financial instruments as defined in FRS102. The financial assets and financial liabilities of the company and their measurement basis are as follows:

Financial assets - trade and other debtors are basic financial instruments and are debt instruments measured at amortised cost. Prepayments are not financial instruments. Cash at bank is classified as a basic financial instrument and is measured at amortised cost.

Financial liabilities - trade creditors, accruals and other creditors and basic financial instruments and are measured at amortised cost. Taxation and social security and not included in the financial instruments disclosure definition.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Debtors
Short term debtors are initially measured at transaction price less attributable costs. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Creditors
Short term trade creditors are initially measured at transaction price less attributable costs. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

MEDICAL SOLUTIONS DELIVERED LTD (REGISTERED NUMBER: 04082214)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 October 2023
and 30 September 2024 2,075
DEPRECIATION
At 1 October 2023 1,105
Charge for year 243
At 30 September 2024 1,348
NET BOOK VALUE
At 30 September 2024 727
At 30 September 2023 970

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 4,420 3,050
Other debtors 814 2,941
5,234 5,991

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 656 527
Other creditors 1,573 -
2,229 527

7. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 182 184

Deferred
tax
£   
Balance at 1 October 2023 184
Provided during year (2 )
Balance at 30 September 2024 182

MEDICAL SOLUTIONS DELIVERED LTD (REGISTERED NUMBER: 04082214)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100

9. RELATED PARTY DISCLOSURES

At the year end a director was owed £1,573 (2023 - (£2,253)). Interest has been charged at official interest rates on instances where the director owed the company. The loan is unsecured and repayable on demand.

10. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is C Loveday.